David L Nicol
Overview
Explore the profile of David L Nicol including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1441
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wood G, Chamberlain F, Tran B, Conduit C, Liow E, Nicol D, et al.
Nat Rev Urol
. 2023 Mar;
20(8):502-512.
PMID: 36882564
International Germ Cell Cancer Collaborative Group good-risk metastatic seminoma has cure rates of >95%. Within this risk group, patients with stage II disease exhibit the best oncological outcomes with the...
2.
3.
Alifrangis C, Nicol D, Shamash J, Rajan P
Scott Med J
. 2022 May;
67(3):126-128.
PMID: 35509203
Background And Aims: Testicular Germ Cell Tumours (TGCTs) are the commonest young adult male cancer, with excellent survival outcomes even with metastatic disease. Chemotherapy, radiotherapy, and surgery are international guideline-dictated...
4.
Pearce A, Manson-Bahr D, Reid A, Huddart R, Mayer E, Nicol D
Eur Urol Open Sci
. 2021 Nov;
33:83-88.
PMID: 34723218
Background: Retroperitoneal lymph node dissection (RPLND) is essential for the treatment of metastatic germ cell tumours of the testis. Recommendations on the referral and management of complex urological cancers in...
5.
Jay A, Aldiwani M, OCallaghan M, Pearce A, Huddart R, Mayer E, et al.
Eur Urol Open Sci
. 2021 Aug;
29:82-88.
PMID: 34337537
Background: Late relapse (LR) of nonseminomatous germ cell tumour (NSGCT) is uncommon, with limited data published. LR is defined as relapse occurring after a disease-free interval of 2 yr. Objective:...
6.
Loveday C, Sud A, Jones M, Broggio J, Scott S, Gronthound F, et al.
Gut
. 2020 Aug;
70(6):1053-1060.
PMID: 32855306
Objective: To evaluate the impact of faecal immunochemical testing (FIT) prioritisation to mitigate the impact of delays in the colorectal cancer (CRC) urgent diagnostic (2-week-wait (2WW)) pathway consequent from the...
7.
Sud A, Torr B, Jones M, Broggio J, Scott S, Loveday C, et al.
Lancet Oncol
. 2020 Jul;
21(8):1035-1044.
PMID: 32702311
Background: During the COVID-19 lockdown, referrals via the 2-week-wait urgent pathway for suspected cancer in England, UK, are reported to have decreased by up to 84%. We aimed to examine...
8.
Ap Dafydd D, Messiou C, Thway K, Strauss D, Nicol D, Moskovic E
Urology
. 2016 Sep;
100:163-168.
PMID: 27639792
Objective: To describe the major imaging features, together with clinical data, of paratesticular sarcomas. Materials And Methods: A retrospective analysis was performed of available imaging and clinical data of 77...
9.
Gardiner R, Yaxley J, Pakenham K, Green H, Mactaggart P, Watson R, et al.
J Clin Oncol
. 2015 Oct;
33(36):4314-5.
PMID: 26503208
No abstract available.
10.
Greenwell T, Castle C, Nicol D
Scand J Urol
. 2015 Oct;
50(1):71-3.
PMID: 26428415
Objective: The aim of this study was to assess the effect of clean intermittent self-catheterization (CISC) on stricture recurrence. Materials And Methods: The incidence of stricture recurrence was assessed retrospectively...